Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture
NCT ID: NCT01626625
Last Updated: 2012-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
10 participants
INTERVENTIONAL
2010-04-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting
NCT01429012
Evaluation the Treatment of Nonunion of Long Bone Fracture of Lower Extremities (Femur and Tibia) Using Mononuclear Stem Cells From the Iliac Wing Within a 3-D Tissue Engineered Scaffold
NCT01958502
The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital
NCT01788059
Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)
NCT06103396
Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union
NCT03794622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stem cells
stem cells + hydroxy apatite
stem cells + hydroxy apatite
patient will be transplanted with stem cells and hydroxyapatite
autograft
autograft taken from iliac crest
patient will be transplanted with autograft
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stem cells + hydroxy apatite
patient will be transplanted with stem cells and hydroxyapatite
autograft taken from iliac crest
patient will be transplanted with autograft
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active infection,
* pathological fracture,
* ongoing hormonal therapy
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ismail Hadisoebroto Dilogo
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RSCM
Jakarta, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NONUNISTEM1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.